moclobemide has been researched along with almotriptan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Azie, NE; Bell, DJ; Burke, MT; Carel, BJ; Fleishaker, JC; Jansat, JM; Ryan, KK | 1 |
1 trial(s) available for moclobemide and almotriptan
Article | Year |
---|---|
Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans.
Topics: Adolescent; Adult; Cross-Over Studies; Drug Interactions; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Serotonin Receptor Agonists; Tryptamines | 2001 |
2 other study(ies) available for moclobemide and almotriptan
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |